FDA fast-tracks personalized therapy for hard-to-treat-prostate cancer By Paul McClure July 02, 2024 A novel combination treatment for advanced prostate cancer has been granted Fast Track status by ...

Please provide your email address to receive an email when new articles are posted on . Tonmya significantly reduced daily pain vs. placebo in a phase 3 trial in fibromyalgia. Fast track designation ...

JSKN003 has shown a 63% objective response rate and 7.7 months median progression-free survival in PROC patients, with higher efficacy in HER2-positive subgroups. The FDA's fast track designation ...

Sabrina Gonzalez doesn’t think many children dream of being an insurance agent when they grow up. She didn’t. But Gonzalez is proud to be a licensed property/casualty insurance agent today. And she ...

Treatment with DD01 treatment reduced hepatic steatosis by more than 50% in 4 weeks, according to phase 1 data. The Food and Drug Administration (FDA) has granted Fast Track designation to DD01 for ...

Avenzo Therapeutics Granted Fast Track Designation for AVZO-1418, a Potential Best-in-Class EGFR/HER3 Bispecific Antibody-Drug Conjugate, for the Treatment of Patients with EGFR-Mutated TKI-Pretreated ...